177 related articles for article (PubMed ID: 7833220)
1. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
Cockcroft JR; Chowienczyk PJ; Brett SE; Bender N; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):317-21. PubMed ID: 7833220
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Witherow FN; Helmy A; Webb DJ; Fox KA; Newby DE
Circulation; 2001 Oct; 104(18):2177-81. PubMed ID: 11684627
[TBL] [Abstract][Full Text] [Related]
3. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
Brown NJ; Gainer JV; Murphey LJ; Vaughan DE
Circulation; 2000 Oct; 102(18):2190-6. PubMed ID: 11056091
[TBL] [Abstract][Full Text] [Related]
5. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm.
Cockcroft JR; Chowienczyk PJ; Brett SE; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473
[TBL] [Abstract][Full Text] [Related]
6. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Legat FJ; Griesbacher T; Lembeck F
Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
[TBL] [Abstract][Full Text] [Related]
7. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
Hornig B; Kohler C; Schlink D; Tatge H; Drexler H
Hypertension; 2003 May; 41(5):1092-5. PubMed ID: 12654707
[TBL] [Abstract][Full Text] [Related]
8. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
Gainer JV; Morrow JD; Loveland A; King DJ; Brown NJ
N Engl J Med; 1998 Oct; 339(18):1285-92. PubMed ID: 9791144
[TBL] [Abstract][Full Text] [Related]
9. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature.
Lauer T; Kleinbongard P; Preik M; Rauch BH; Deussen A; Feelisch M; Strauer BE; Kelm M
Basic Res Cardiol; 2003 Mar; 98(2):84-9. PubMed ID: 12607129
[TBL] [Abstract][Full Text] [Related]
10. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
Yekebas E; Treede H; Jochum M; Gippner-Steppert C; Bloechle C; Knoefel WT; Scholz J; Fink E; Izbicki JR
Crit Care Med; 2000 Apr; 28(4):1119-27. PubMed ID: 10809293
[TBL] [Abstract][Full Text] [Related]
12. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.
Hornig B; Kohler C; Drexler H
Circulation; 1997 Mar; 95(5):1115-8. PubMed ID: 9054837
[TBL] [Abstract][Full Text] [Related]
13. Effect of early blockade of bradykinin B2-receptors on the blood pressure phenotype of normotensive and spontaneously hypertensive rats.
Emanueli C; Madeddu P
Pharmacol Res; 1997 Jun; 35(6):522-6. PubMed ID: 9361315
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
[TBL] [Abstract][Full Text] [Related]
16. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men.
Squire IB; O'Kane KP; Anderson N; Reid JL
Hypertension; 2000 Jul; 36(1):132-6. PubMed ID: 10904025
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization.
Honing ML; Smits P; Morrison PJ; Rabelink TJ
Hypertension; 2000 Jun; 35(6):1314-8. PubMed ID: 10856283
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
[TBL] [Abstract][Full Text] [Related]
20. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
